En-Clofert 50 Softgel Capsule

En-Clofert 50 Softgel Capsule belongs to a group of medicines called ovulation stimulants. It is used for treating infertility in women who are not ovulating properly. Female infertility is a condition in which a woman is unable to conceive despite frequent unprotected sex for at least a year. 

En-Clofert 50 Softgel Capsule contains a medicine called Enclomiphene. It works by stimulating the release of eggs from the ovary (ovulation).

En-Clofert 50 Softgel Capsule is a prescription-only medicine. Take En-Clofert 50 Softgel Capsule as prescribed. En-Clofert 50 Softgel Capsule may be taken with or without food. In some cases, En-Clofert 50 Softgel Capsule may cause certain common side effects such as nausea, vomiting, heavy bleeding at the initial stage, weight gain and headaches. Most of these side effects do not require medical attention and will resolve gradually over time. However, you are advised to talk to your doctor if these side effects persist or worsen. 

It is recommended not to take En-Clofert 50 Softgel Capsule if you are hypersensitive (allergic) to Enclomiphene or any of the other ingredients of En-Clofert 50 Softgel Capsule. Signs of allergic reactions, having or ever had liver disease, having unusual menstrual bleeding where the cause is unknown, having a type of cancer that is made worse by hormones, or having a cyst on your ovary. The use of alcohol is prohibited. It is recommended not to use in populations below 18 years. You may notice problems with your eyesight, such as blurred vision while taking En-Clofert 50 Softgel Capsule. If this happens, do not drive or use any tools or machines.

En-Clofert 50 Softgel Capsule contains Enclomiphene, an ovarian stimulant and selective oestrogen receptor modulator. It is used primarily to improve female fertility in those suffering from problems related to the proper release of egg cells (ovulation). It regulates oestrogen levels in the body and increases the release of gonadotropic hormones FSH and LH. FSH and LH, in turn, act on the ovaries and follicles to augment the liberation of eggs from inside the follicles, thereby making the egg cells available and approachable for fertilisation by male sperm. In conjunction, En-Clofert 50 Softgel Capsule treats infertility and improves overall hormonal and gynaecological health.

En-Clofert 50 Softgel Capsule is not recommended in post-menopausal women, children or men or known allergy to either of the components. En-Clofert 50 Softgel Capsule may increase the risk of ovarian cancer. Keep your doctor informed of your entire medical history, including any history of early menopause or have been told you are infertile or have stopped having periods because you are under-weight, or have had fits or seizures in the past or have ‘fibroids’ in your womb or have ‘polycystic’ ovaries or with ovaries are swollen or have hypertriglyceridemia (an excess of fats in the blood) or a family history of hypertriglyceridemia.

• Do not discontinue taking En-Clofert 50 Softgel Capsule abruptly or without the advice of the physician.
• Please know that your doctor may order blood tests to check your hormone levels while you are on En-Clofert 50 Softgel Capsule. 
• Bring any mood swings or mood changes to your doctor’s attention. Please see a mental health care professional if need be. 
• Before starting En-Clofert 50 Softgel Capsule, speak to your doctor about the risk of multiple pregnancies (twins or triplets) and ectopic pregnancy (where the baby grows outside the uterus).